IMIDAZOLIDINDIONDERIVATE

European patent · EP2509961 · Deleted

Register entry

Publication number
EP2509961
Application number
EP10788314
Kind
European patent with effect for Switzerland and Liechtenstein
Status
Deleted
Specification
Granted
Filed
Dec 6, 2010
Published
Oct 17, 2012
Granted
Mar 9, 2016
Deleted
Jul 23, 2022
Reason
Annual fee unpaid
IPC classes
C07D 233/76 (2006.01)
C07D 401/04 (2006.01)
C07D 403/04 (2006.01)
A61K 31/4166 (2006.01)
A61P 25/18 (2006.01)
Priority
GB 0921760 11.12.2009
GB 201012924 30.07.2010
PCT application
PCT/EP2010/068946 06.12.2010
PCT publication
WO2011/069951 16.06.2011
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Jul 23, 2022

    Deleted, fee unpaid

    Published in Swissreg on 23.07.2022

  2. May 14, 2016

    Agent entered

    Representative
    Isler & Pedrazzini AG, Postfach 1772, 8027 Zürich

    Published in Swissreg on 14.05.2016

  3. Mar 9, 2016

    Granted

    Published in Swissreg on 09.03.2016

Parties

Holder

Autifony Therapeutics Limited

90 High Holborn, London WC1V 6XX, GB

Agent

Isler & Pedrazzini AG

Postfach 1772, 8027 Zürich

Inventor

ALVARO, Giuseppe

I-37135 Verona, IT

DECOR, Anne

I-37135 Verona, IT

FONTANA, Stefano

I-37135 Verona, IT

HAMPRECHT, Dieter

I-37135 Verona, IT

LARGE, Charles

I-37135 Verona, IT

MARASCO, Agostino

I-37135 Verona, IT

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.